A cornea transplant becomes necessary when the clear, dome-shaped front layer of the eye is too damaged, diseased, or misshapen to provide usable vision, and no less invasive treatment can fix the problem. The most common reasons include a condition called keratoconus (where the cornea thins and bulges), a genetic disease called Fuchs’ dystrophy, scarring from infections or injuries, and swelling caused by previous eye surgeries. Each of these affects the cornea differently, but they share the same endpoint: light can no longer pass cleanly through to the retina, and vision deteriorates beyond what glasses or contacts can correct.
Keratoconus: A Cornea That Changes Shape
Keratoconus is one of the leading reasons people end up needing a transplant, particularly younger adults. The cornea gradually loses collagen, the structural protein that keeps it round and firm. This happens because of an imbalance between how quickly corneal cells produce tissue and how quickly they break it down. Over time, the cornea thins and pushes outward into a cone-like shape, distorting vision in ways that feel like looking through a warped window.
Early on, glasses can compensate. As the condition progresses, rigid contact lenses become necessary because they create a smooth optical surface over the irregular cornea. But in advanced cases, even hard contacts become too uncomfortable to wear or can’t deliver clear vision anymore. At that point, a transplant is the remaining option. Younger patients with rapidly advancing keratoconus are more likely to reach this stage.
Fuchs’ Dystrophy: Cells That Stop Pumping
Your cornea stays clear because a single layer of cells on its back surface constantly pumps excess fluid out. These endothelial cells act like tiny bilge pumps, maintaining exactly the right fluid balance for transparency. In Fuchs’ dystrophy, a genetic condition, these cells gradually die off. The problem is that endothelial cells don’t regenerate. Once they’re gone, fluid accumulates, the cornea swells, and vision becomes hazy or cloudy.
The disease typically worsens over years or decades. Many people notice that their vision is worst in the morning (because fluid builds up overnight when the eyes are closed) and improves slightly as the day goes on. Eventually, the swelling becomes permanent. Fuchs’ dystrophy is one of the conditions where newer partial-thickness transplant techniques have made the biggest difference, since only the damaged back layer of the cornea needs replacing rather than the entire thing.
Scarring From Infection or Injury
The cornea can scar just like skin does, but even a small scar in the visual pathway blocks or scatters light enough to impair vision significantly. Two of the most common causes are herpes simplex virus (the same virus family that causes cold sores) and bacterial infections, particularly from improper contact lens use.
Herpes simplex keratitis usually heals without permanent damage the first time, but the virus lives in nerve tissue and can reactivate repeatedly. Each flare-up risks deeper scarring. When scarring accumulates in the central cornea, it creates a permanent cloudy patch that no medication can reverse. The CDC notes that untreated or repeatedly recurring infections can lead to blindness. Physical trauma, such as chemical burns, metal fragments, or other workplace and household injuries, can also leave scars dense enough to require a transplant.
Swelling After Previous Eye Surgery
Cataract surgery and other procedures inside the eye can sometimes damage those same endothelial cells on the back of the cornea. This leads to a condition where the cornea swells and clouds over, sometimes weeks or months after the original surgery. It’s essentially the same mechanism as Fuchs’ dystrophy, just triggered by surgical trauma rather than genetics. This complication is one of the more common indications for transplant overall, and it’s a reason surgeons monitor corneal health carefully before and after any intraocular procedure.
Corneal Ulcers That Won’t Heal
A corneal ulcer is an open sore on the cornea, usually caused by bacterial, fungal, or parasitic infection. Most respond to aggressive antibiotic or antifungal treatment. When they don’t, the ulcer can deepen, thin the cornea dangerously, or leave behind dense scarring. In these cases, a transplant serves a dual purpose: it removes the infected or destroyed tissue and restores a clear optical surface.
Full vs. Partial Transplants
Not all cornea transplants are the same procedure. The type depends entirely on which layer of the cornea is damaged. A full-thickness transplant replaces the entire cornea and is used when damage extends through all layers, such as deep scarring from trauma. For conditions like keratoconus, where the problem is in the front and middle layers but the back endothelial cells are healthy, surgeons can replace just the front portion. This eliminates the risk of the body rejecting the endothelial layer entirely.
For Fuchs’ dystrophy and post-surgical swelling, where only the back layer has failed, newer techniques replace just that thin endothelial sheet. These partial transplants have dramatically improved outcomes. One technique has a rejection rate of only about 2%, compared to significantly higher rates with full-thickness procedures. They also recover faster: stitches from a partial transplant typically come out in 2 to 4 months, while a full-thickness transplant requires stitches to stay in place for 18 to 24 months.
How Long a Transplant Lasts
Survival rates vary by technique and underlying condition. For endothelial disease like Fuchs’ dystrophy, partial-thickness grafts have a five-year survival rate of about 83%, compared to 64% for traditional full-thickness transplants. At the ten-year mark, the gap widens further: roughly 74% versus 51%. Fuchs’ dystrophy specifically has some of the best long-term outcomes, with nearly 90% of partial-thickness grafts surviving a decade.
After stitches are removed, about half of transplant recipients still need glasses or contact lenses for their best corrected vision. A transplant restores clarity to the cornea, but it doesn’t guarantee perfect unaided sight. Astigmatism from the graft is common, and fine-tuning with corrective lenses is a normal part of the process.
Where Donor Tissue Comes From
Corneal tissue comes from deceased donors through eye banks. The screening process is rigorous. Both the FDA and the Eye Bank Association of America require a thorough review of each donor’s medical and social history to rule out communicable diseases. Donors are screened for signs of active infection, including fever, abnormal blood counts, and positive blood cultures. If two or more signs of systemic infection are present, a medical director must personally review the case before the tissue can be cleared. This careful vetting is one reason corneal transplants have an excellent safety record for transmitted infection.
Unlike organ transplants that require blood-type matching and anti-rejection drugs for life, the cornea has no blood vessels in most cases, which makes it uniquely tolerant of transplanted tissue. Most recipients use steroid eye drops for months to years to prevent rejection, but systemic immunosuppression is rarely needed.